Ophir A, Blumenkranz M S, Claflin A J
Am J Ophthalmol. 1982 Oct;94(4):450-7. doi: 10.1016/0002-9394(82)90238-0.
An experimental model of massive periretinal proliferation and intraocular neovascularization, produced in rabbits by the intravitreal injection of 250,00 cultured heterologous fibroblasts, showed no significant difference in the detachment rate (69% to 100%) or neovascularization rate (45% to 88%) between the animals injected with autologous cells and those injected with heterologous cells. Dermal fibroblasts produced a slightly higher detachment rate than conjunctival fibroblasts and were equally effective after reconstitution and subculture from liquid nitrogen storage in 7% dimethyl sulfoxide. Heterologous cells produced no clinical or histologic evidence of rejection when compared with autologous cells in the same animal and had the following advantages: (1) elimination of several biopsies and extended cell culture time; (2) a ready source of cryopreserved cells is available; (3) multiple injections of many animals can be performed within a short time; (4) in vivo and in vitro drug testing can be correlated on the same cell line.
通过向兔眼玻璃体内注射250,000个培养的异种成纤维细胞建立的大规模视网膜周增殖和眼内新生血管形成的实验模型显示,注射自体细胞的动物与注射异种细胞的动物在脱离率(69%至100%)或新生血管形成率(45%至88%)方面无显著差异。真皮成纤维细胞产生的脱离率略高于结膜成纤维细胞,并且在从液氮储存于7%二甲基亚砜中复溶和传代培养后效果相同。与同一动物体内的自体细胞相比,异种细胞未产生临床或组织学排斥证据,并且具有以下优点:(1)无需多次活检和延长细胞培养时间;(2)有现成的冷冻保存细胞来源;(3)可在短时间内对多只动物进行多次注射;(4)可在同一细胞系上关联体内和体外药物测试。